Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study.
Hemasphere. 2023 Aug 30;7(9):e942. doi: 10.1097/HS9.0000000000000942. eCollection 2023 Sep.
Hemasphere. 2023.
PMID: 37663672
Free PMC article.
Comorbidities in multiple myeloma and implications on survival: A population-based study.
Sverrisdóttir IS, Rögnvaldsson S, Thorsteinsdottir S, Gíslason GK, Aspelund T, Turesson I, Björkholm M, Gregersen H, Hveding Blimark C, Landgren O, Kristinsson SY.
Sverrisdóttir IS, et al. Among authors: hveding blimark c.
Eur J Haematol. 2021 Jun;106(6):774-782. doi: 10.1111/ejh.13597. Epub 2021 Mar 11.
Eur J Haematol. 2021.
PMID: 33565126
Item in Clipboard
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry.
Wålinder G, Samuelsson J, Näsman P, Hansson M, Juliusson G, Forsberg K, Svensson R, Linder O, Carlson K, Kristinsson SY, Mellqvist UH, Hveding Blimark C, Turesson I, Nahi H.
Wålinder G, et al. Among authors: hveding blimark c.
Eur J Haematol. 2020 May;104(5):376-382. doi: 10.1111/ejh.13351. Epub 2020 Feb 22.
Eur J Haematol. 2020.
PMID: 31733147
Item in Clipboard
The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patients.
Veskovski L, Jakobsson I, Andersson PO, Gustafsson T, Sedigh A, Knut-Bojanowska D, Hansson M, Hveding Blimark C, Mellqvist UH.
Veskovski L, et al. Among authors: hveding blimark c.
EJHaem. 2024 Apr 9;5(3):455-461. doi: 10.1002/jha2.886. eCollection 2024 Jun.
EJHaem. 2024.
PMID: 38895087
Free PMC article.
Item in Clipboard
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.
Dimopoulos MA, et al.
Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10.
Lancet. 2019.
PMID: 30545780
Clinical Trial.
Item in Clipboard
Cite
Cite